Cassava Sciences | Driftskostnader



Operating Expenses Endring Dato
Abbott USD 9.06B 298M 2024-12
Amgen USD 6.78B 401M 2024-12
Biogen USD 2.01B 13.3M 2024-12
Cassava Sciences USD 29.49M 1.14M 2024-12
Eisai JPY 188.58B 7.01B 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
Geron USD 69.29M 12.81M 2024-12
J&J USD 18.63B 500M 2024-12
Merck USD 11.33B 1.4B 2024-12
Novartis USD 11.28B 1.73B 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12



Cassava Sciences Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.